Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for forehead wounds after Mohs surgery
NCT01459666Phase 4Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Sep 2011
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in cicatrix, sponsored by University Hospitals Cleveland Medical Center. Started Sep 2011; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
cicatrix
Beyond the preview
Go deeper on NCT01459666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459666.